Radhika Sivaramakrishna, PhD, PMP, CSSBB, CCRP, is currently a consultant providing her expertise in clinical operations, project management, process excellence, clinical outsourcing, and other related areas. Prior to this, she was Executive Director, Clinical Operations and Project Management at Rainier Therapeutics, where she not only served as the global lead on several studies, but also led project management across all functions. She is PMP-certified, is an ASQ-certified black belt, and has a CCRP certification through SOCRA. Previously, she had served in several roles of increasing responsibility both in academia as well as industry CRO and sponsor companies. Prior to Rainier Therapeutics, she was Senior Director of Clinical Outsourcing, Operational Excellence and Project Management at Dynavax where she oversaw relationships with all clinical vendors as well as led multiple infrastructure process improvement initiatives.
Prior to Dynavax, Dr. Sivaramakrishna spent several years at Covance, where her most recent position was Executive Director, Alliance Management. In this role, she was responsible for overall global program and portfolio management for several pharmaceutical/biotech sponsor clients holding ultimate accountability for successful delivery of clinical trials that Covance runs for these clients. Prior to this, at the Immune Tolerance Network, UCSF, she was Senior Director, Clinical Operations where she managed a department of 13 individuals and was not only overall responsible for 30+ clinical trials in the areas of transplantation, T1 diabetes, allergy, MS, and other autoimmune disorders but was also responsible for overall process standardization and project management. Dr. Sivaramakrishna also served on the board of SOCRA for several years and is on the project and program management faculty for SOCRA’s conferences. She is also faculty for the clinical research certificate program at UC Berkeley Extensions, as well as was invited by UC San Diego Extension to develop a course on project management in clinical trials, a course that has been running since 2017.